1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids : Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery
2025) In Annals of Neurology(
- Contribution to journal › Article
- 2024
-
Mark
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders : An International, Multicenter Study
(
- Contribution to journal › Article
-
Mark
COMBAT-MS : A Population-Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
(
- Contribution to journal › Article
- 2022
-
Mark
Effect Modification between Genes and Environment and Parkinson's Disease Risk
(
- Contribution to journal › Scientific review
- 2021
-
Mark
DNase Treatment Prevents Cerebrospinal Fluid Block in Early Experimental Pneumococcal Meningitis
(
- Contribution to journal › Article
- 2020
-
Mark
Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
(
- Contribution to journal › Article
-
Mark
Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage
(
- Contribution to journal › Article
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article